Franco Vitaliano
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$10.9MFederal grants as PI16 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
16 awards · $10.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 19, 2025 | NIH | SBIR Phase II New Nanoprobes for MR Imaging of TrkB in Alzheimer's Disease | $500K | ExQor Technologies Inc |
| Aug 19, 2024 | NIH | SBIR Phase II New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease | $996K | ExQor Technologies Inc |
| Jul 27, 2023 | NIH | SBIR Phase II New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease | $996K | ExQor Technologies Inc |
| Sep 21, 2022 | NIH | SBIR Phase II New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease | $1.0M | ExQor Technologies Inc |
| Aug 22, 2022 | NIH | SBIR Phase II New targeted BDNF nanoparticles for treatment of METH addiction and neurotoxicity | $1.2M | ExQor Technologies Inc |
| Aug 24, 2021 | NIH | SBIR Phase II New targeted BDNF nanoparticles for treatment of METH addiction and neurotoxicity | $1.2M | ExQor Technologies Inc |
| Apr 9, 2020 | NIH | SBIR Phase II New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease | $100K | ExQor Technologies Inc |
| Aug 19, 2019 | NIH | SBIR Phase II Preventing and Reducing HAND by Using New BDNF Nanoprobes | $750K | ExQor Technologies Inc |
| May 27, 2019 | NIH | SBIR Phase II New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease | $749K | ExQor Technologies Inc |
| Sep 11, 2018 | NIH | SBIR Phase II New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease | $750K | ExQor Technologies Inc |
| Sep 7, 2018 | NIH | SBIR Phase II Preventing and Reducing HAND by Using New BDNF Nanoprobes | $539K | ExQor Technologies Inc |
| Sep 7, 2018 | NIH | SBIR Phase II Preventing and Reducing HAND by Using New BDNF Nanoprobes | $1.3M | ExQor Technologies Inc |
| Sep 11, 2017 | NIH | SBIR Phase II New BDNF Nanoparticles for Early Treatment of Alzheimer's Disease | $225K | ExQor Technologies Inc |
| Mar 21, 2017 | NIH | SBIR Phase I New Targeted BDNF Nanoparticles for Treatment of Dopaminergic Neurodegeneration in METH Addiction and HAND | $225K | ExQor Technologies Inc |
| Jul 7, 2016 | NIH | SBIR Phase I Preventing and Reducing HAND by Using New BDNF Nanoprobes | $214K | ExQor Technologies Inc |
| Jul 7, 2015 | NIH | SBIR Phase I Preventing and Reducing HAND by Using New BDNF Nanoprobes | $225K | ExQor Technologies Inc |
Peer ranks
Federal funding#54
Awards as PI#37
Patents#273
Companies
- ExQor Technologies IncLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.